Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation
Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology ( CLN1-14 ). Recently, mutations in the DNAJC5/CLN4 gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been iden...
Gespeichert in:
Veröffentlicht in: | Acta neuropathologica 2015-12, Vol.131 (4), p.621-637 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 637 |
---|---|
container_issue | 4 |
container_start_page | 621 |
container_title | Acta neuropathologica |
container_volume | 131 |
creator | Henderson, Michael X. Wirak, Gregory S. Zhang, Yong-quan Dai, Feng Ginsberg, Stephen D. Dolzhanskaya, Natalia Staropoli, John F. Nijssen, Peter CG Lam, TuKiet T Roth, Amy F. Davis, Nicholas G. Dawson, Glyn Velinov, Milen Chandra, Sreeganga S. |
description | Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (
CLN1-14
). Recently, mutations in the
DNAJC5/CLN4
gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (
PPT1/CLN1
) are biochemically linked. We find that in
DNAJC5/CLN4
patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSP is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and
DNAJC5/CLN4
patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways. |
doi_str_mv | 10.1007/s00401-015-1512-2 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4791186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4791186</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_47911863</originalsourceid><addsrcrecordid>eNqljM1KxDAURoMoTv15AHf3BeokadM6G0GqIi6GgrMPaZuZXkmTkqTj9O0t4sa1q4-PcziE3DF6zygt14HSnLKUMpEywXjKz0jC8oynVGTZOUkoXWiRcb4iVyF8Lo-XubgkK14UYiPKMiGnrZ68s8pAq73DDgyObj-FFq0LGOALYw_P26f3SqyrjxqGKaqIzgbo1VFDXe8YjCr2zrjDDMp2oE89NhhBNdp7ZSOM3kWNdtHMgNHN5idwQy72ygR9-7vX5PH1ZVe9pePUDLprtY1eGTl6HJSfpVMo_xKLvTy4o8zLDWMPRfbvwDdnOm1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation</title><source>Springer Nature - Complete Springer Journals</source><creator>Henderson, Michael X. ; Wirak, Gregory S. ; Zhang, Yong-quan ; Dai, Feng ; Ginsberg, Stephen D. ; Dolzhanskaya, Natalia ; Staropoli, John F. ; Nijssen, Peter CG ; Lam, TuKiet T ; Roth, Amy F. ; Davis, Nicholas G. ; Dawson, Glyn ; Velinov, Milen ; Chandra, Sreeganga S.</creator><creatorcontrib>Henderson, Michael X. ; Wirak, Gregory S. ; Zhang, Yong-quan ; Dai, Feng ; Ginsberg, Stephen D. ; Dolzhanskaya, Natalia ; Staropoli, John F. ; Nijssen, Peter CG ; Lam, TuKiet T ; Roth, Amy F. ; Davis, Nicholas G. ; Dawson, Glyn ; Velinov, Milen ; Chandra, Sreeganga S.</creatorcontrib><description>Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (
CLN1-14
). Recently, mutations in the
DNAJC5/CLN4
gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (
PPT1/CLN1
) are biochemically linked. We find that in
DNAJC5/CLN4
patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSP is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and
DNAJC5/CLN4
patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.</description><identifier>ISSN: 0001-6322</identifier><identifier>EISSN: 1432-0533</identifier><identifier>DOI: 10.1007/s00401-015-1512-2</identifier><identifier>PMID: 26659577</identifier><language>eng</language><ispartof>Acta neuropathologica, 2015-12, Vol.131 (4), p.621-637</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Henderson, Michael X.</creatorcontrib><creatorcontrib>Wirak, Gregory S.</creatorcontrib><creatorcontrib>Zhang, Yong-quan</creatorcontrib><creatorcontrib>Dai, Feng</creatorcontrib><creatorcontrib>Ginsberg, Stephen D.</creatorcontrib><creatorcontrib>Dolzhanskaya, Natalia</creatorcontrib><creatorcontrib>Staropoli, John F.</creatorcontrib><creatorcontrib>Nijssen, Peter CG</creatorcontrib><creatorcontrib>Lam, TuKiet T</creatorcontrib><creatorcontrib>Roth, Amy F.</creatorcontrib><creatorcontrib>Davis, Nicholas G.</creatorcontrib><creatorcontrib>Dawson, Glyn</creatorcontrib><creatorcontrib>Velinov, Milen</creatorcontrib><creatorcontrib>Chandra, Sreeganga S.</creatorcontrib><title>Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation</title><title>Acta neuropathologica</title><description>Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (
CLN1-14
). Recently, mutations in the
DNAJC5/CLN4
gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (
PPT1/CLN1
) are biochemically linked. We find that in
DNAJC5/CLN4
patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSP is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and
DNAJC5/CLN4
patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.</description><issn>0001-6322</issn><issn>1432-0533</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqljM1KxDAURoMoTv15AHf3BeokadM6G0GqIi6GgrMPaZuZXkmTkqTj9O0t4sa1q4-PcziE3DF6zygt14HSnLKUMpEywXjKz0jC8oynVGTZOUkoXWiRcb4iVyF8Lo-XubgkK14UYiPKMiGnrZ68s8pAq73DDgyObj-FFq0LGOALYw_P26f3SqyrjxqGKaqIzgbo1VFDXe8YjCr2zrjDDMp2oE89NhhBNdp7ZSOM3kWNdtHMgNHN5idwQy72ygR9-7vX5PH1ZVe9pePUDLprtY1eGTl6HJSfpVMo_xKLvTy4o8zLDWMPRfbvwDdnOm1A</recordid><startdate>20151210</startdate><enddate>20151210</enddate><creator>Henderson, Michael X.</creator><creator>Wirak, Gregory S.</creator><creator>Zhang, Yong-quan</creator><creator>Dai, Feng</creator><creator>Ginsberg, Stephen D.</creator><creator>Dolzhanskaya, Natalia</creator><creator>Staropoli, John F.</creator><creator>Nijssen, Peter CG</creator><creator>Lam, TuKiet T</creator><creator>Roth, Amy F.</creator><creator>Davis, Nicholas G.</creator><creator>Dawson, Glyn</creator><creator>Velinov, Milen</creator><creator>Chandra, Sreeganga S.</creator><scope>5PM</scope></search><sort><creationdate>20151210</creationdate><title>Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation</title><author>Henderson, Michael X. ; Wirak, Gregory S. ; Zhang, Yong-quan ; Dai, Feng ; Ginsberg, Stephen D. ; Dolzhanskaya, Natalia ; Staropoli, John F. ; Nijssen, Peter CG ; Lam, TuKiet T ; Roth, Amy F. ; Davis, Nicholas G. ; Dawson, Glyn ; Velinov, Milen ; Chandra, Sreeganga S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_47911863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Henderson, Michael X.</creatorcontrib><creatorcontrib>Wirak, Gregory S.</creatorcontrib><creatorcontrib>Zhang, Yong-quan</creatorcontrib><creatorcontrib>Dai, Feng</creatorcontrib><creatorcontrib>Ginsberg, Stephen D.</creatorcontrib><creatorcontrib>Dolzhanskaya, Natalia</creatorcontrib><creatorcontrib>Staropoli, John F.</creatorcontrib><creatorcontrib>Nijssen, Peter CG</creatorcontrib><creatorcontrib>Lam, TuKiet T</creatorcontrib><creatorcontrib>Roth, Amy F.</creatorcontrib><creatorcontrib>Davis, Nicholas G.</creatorcontrib><creatorcontrib>Dawson, Glyn</creatorcontrib><creatorcontrib>Velinov, Milen</creatorcontrib><creatorcontrib>Chandra, Sreeganga S.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta neuropathologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henderson, Michael X.</au><au>Wirak, Gregory S.</au><au>Zhang, Yong-quan</au><au>Dai, Feng</au><au>Ginsberg, Stephen D.</au><au>Dolzhanskaya, Natalia</au><au>Staropoli, John F.</au><au>Nijssen, Peter CG</au><au>Lam, TuKiet T</au><au>Roth, Amy F.</au><au>Davis, Nicholas G.</au><au>Dawson, Glyn</au><au>Velinov, Milen</au><au>Chandra, Sreeganga S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation</atitle><jtitle>Acta neuropathologica</jtitle><date>2015-12-10</date><risdate>2015</risdate><volume>131</volume><issue>4</issue><spage>621</spage><epage>637</epage><pages>621-637</pages><issn>0001-6322</issn><eissn>1432-0533</eissn><abstract>Neuronal Ceroid Lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (
CLN1-14
). Recently, mutations in the
DNAJC5/CLN4
gene, which encodes the presynaptic co-chaperone CSP were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (
PPT1/CLN1
) are biochemically linked. We find that in
DNAJC5/CLN4
patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSP is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and
DNAJC5/CLN4
patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.</abstract><pmid>26659577</pmid><doi>10.1007/s00401-015-1512-2</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6322 |
ispartof | Acta neuropathologica, 2015-12, Vol.131 (4), p.621-637 |
issn | 0001-6322 1432-0533 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4791186 |
source | Springer Nature - Complete Springer Journals |
title | Neuronal ceroid lipofuscinosis with DNAJC5/CSP mutations have PPT1 pathology and exhibit aberrant protein palmitoylation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A40%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuronal%20ceroid%20lipofuscinosis%20with%20DNAJC5/CSP%20mutations%20have%20PPT1%20pathology%20and%20exhibit%20aberrant%20protein%20palmitoylation&rft.jtitle=Acta%20neuropathologica&rft.au=Henderson,%20Michael%20X.&rft.date=2015-12-10&rft.volume=131&rft.issue=4&rft.spage=621&rft.epage=637&rft.pages=621-637&rft.issn=0001-6322&rft.eissn=1432-0533&rft_id=info:doi/10.1007/s00401-015-1512-2&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4791186%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26659577&rfr_iscdi=true |